Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By

Showing results 111 - 120 of 645

3 November 2022

Philippines Interim National PrEP Guidelines, 2021

The Philippines’ Interim National PrEP Guidelines of 2021 provide details on the delivery of PrEP services for people at substantial risk of HIV infection. These guidelines are intended for use by STI and HIV service providers, coordinators, heads or managers of facilities with HIV services, community-based organizations, and other facilities offering PrEP services from public…

Normative Guidance/Policies

Document
3 November 2022

Philippines HIV Prevention Operational Plan, 2018-20

Building on earlier work, this plan aims to respond to the changing face of the HIV epidemic in the Philippines by broadening options for key populations. Planned initiatives include activities to address human rights-related barriers to HIV prevention, diagnosis, and treatment. In particular, the program will implement guidelines on provision of HIV services for young…

Normative Guidance/Policies

Document
3 November 2022

Peru National HIV/AIDS Guidelines, 2017

This report presents the achievements and challenges of the countries regarding the prevention of HIV infection, highlighting the progress that has been made towards the goals set by the governments of the region to end AIDS in the next years. This new edition continues the successful series of in-depth analyzes on HIV infection in Latin…

Normative Guidance/Policies

Document
3 November 2022

Pakistan National HIV/AIDS Guidelines, 2017

The purpose of Pakistan’s National HIV/AIDS Guidelines of 2017 is to provide guidance on using ARV drugs in the context of the continuum of HIV prevention, treatment and care. The guidance covers the use of ARV drugs for all age groups and populations and it promotes consistency of approaches. These guidelines are intended for physicians,…

Normative Guidance/Policies

Document
3 November 2022

Pakistan AIDS Strategy III, 2015-21

Pakistan’s strategic plan for reaching UNAIDS goals of 90-90-90.

Normative Guidance/Policies

Document
3 November 2022

Nigeria National Oral PrEP Implementation Plan, 2022-24

The purpose of Nigeria’s National Oral PrEP Implementation is the implementation of oral PrEP for HIV prevention and to detail a plan for national introduction and scale-up of oral PrEP from phased approaches to wider implementation.

Normative Guidance/Policies

Document
3 November 2022

Nigeria National HIV/AIDS Strategic Plan, 2017-21

A communication action plan to address the challenge of low level of awareness of HIV self-testing and PrEP services—especially among the key populations and vulnerable groups.

Normative Guidance/Policies

Document
3 November 2022

Nigeria National Strategic Framework on HIV & AIDS, 2017-21

The National HIV and AIDS Strategic Framework (NSF) 2017-2021 succeeds the National HIV and AIDS Strategic Framework 2010-2015 and the National HIV and AIDS Strategic Plan 2010- 2015. This NSF was developed through a highly participatory and consultative process that involved a wide cross-section of stakeholders. The National Strategic Framework has five thematic areas: (i)…

Normative Guidance/Policies

Document
3 November 2022

Nigeria National HIV Self-Testing & PrEP Communication Strategy, 2022

The vision of this document is “an AIDS-free Nigeria, with zero new infection, zero AIDS-related discrimination and stigma, with a broad goal to “fast-track the national response towards ending AIDS in Nigeria by 2030”.

Normative Guidance/Policies

Document
3 November 2022

ICAP Grand Rounds Webinar- Long-Acting Injectable Cabotegravir for HIV Prevention: Promises and Pitfalls

Recording / Slides Two recent landmark HIV Prevention Trials Network (HPTN) studies demonstrated the efficacy of long-acting, injectable cabotegravir (CAB) as PrEP against HIV. These studies showed that CAB for PrEP injected once every eight weeks was superior to daily oral tenofovir/emtricitabine (TDF/FTC) for PrEP among cisgender men and transgender women who have sex with…

Research

Event